4.6 Article

Phenotype Sequencing: Identifying the Genes That Cause a Phenotype Directly from Pooled Sequencing of Independent Mutants

Journal

PLOS ONE
Volume 6, Issue 2, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0016517

Keywords

-

Funding

  1. Office of Science (BER), United States Department of Energy [DE-FC02-02ER63421]

Ask authors/readers for more resources

Random mutagenesis and phenotype screening provide a powerful method for dissecting microbial functions, but their results can be laborious to analyze experimentally. Each mutant strain may contain 50-100 random mutations, necessitating extensive functional experiments to determine which one causes the selected phenotype. To solve this problem, we propose a Phenotype Sequencing'' approach in which genes causing the phenotype can be identified directly from sequencing of multiple independent mutants. We developed a new computational analysis method showing that 1. causal genes can be identified with high probability from even a modest number of mutant genomes; 2. costs can be cut many-fold compared with a conventional genome sequencing approach via an optimized strategy of library-pooling (multiple strains per library) and tag-pooling (multiple tagged libraries per sequencing lane). We have performed extensive validation experiments on a set of E. coli mutants with increased isobutanol biofuel tolerance. We generated a range of sequencing experiments varying from 3 to 32 mutant strains, with pooling on 1 to 3 sequencing lanes. Our statistical analysis of these data (4099 mutations from 32 mutant genomes) successfully identified 3 genes (acrB, marC, acrA) that have been independently validated as causing this experimental phenotype. It must be emphasized that our approach reduces mutant sequencing costs enormously. Whereas a conventional genome sequencing experiment would have cost $7,200 in reagents alone, our Phenotype Sequencing design yielded the same information value for only $1200. In fact, our smallest experiments reliably identified acrB and marC at a cost of only $110-$340.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Genetics & Heredity

Diagnostic utility of transcriptome sequencing for rare Mendelian diseases

Hane Lee, Alden Y. Huang, Lee-kai Wang, Amanda J. Yoon, Genecee Renteria, Ascia Eskin, Rebecca H. Signer, Naghmeh Dorrani, Shirley Nieves-Rodriguez, Jijun Wan, Emilie D. Douine, Jeremy D. Woods, Esteban C. Dell'Angelica, Brent L. Fogel, Martin G. Martin, Manish J. Butte, Neil H. Parker, Richard T. Wang, Perry B. Shieh, Derek A. Wong, Natalie Gallant, Kathryn E. Singh, Y. Jane Tavyev Asher, Janet S. Sinsheimer, Deborah Krakow, Sandra K. Loo, Patrick Allard, Jeanette C. Papp, Christina G. S. Palmer, Julian A. Martinez-Agosto, Stanley F. Nelson

GENETICS IN MEDICINE (2020)

Article Genetics & Heredity

A diagnostic ceiling for exome sequencing in cerebellar ataxia and related neurological disorders

Kathie J. Ngo, Jessica E. Rexach, Hane Lee, Lauren E. Petty, Susan Perlman, Juliana M. Valera, Joshua L. Deignan, Yuanming Mao, Mamdouh Aker, Jennifer E. Posey, Shalini N. Jhangiani, Zeynep H. Coban-Akdemir, Eric Boerwinkle, Donna Muzny, Alexandra B. Nelson, Sharon Hassin-Baer, Gemma Poke, Katherine Neas, Michael D. Geschwind, Wayne W. Grody, Richard Gibbs, Daniel H. Geschwind, James R. Lupski, Jennifer E. Below, Stanley F. Nelson, Brent L. Fogel

HUMAN MUTATION (2020)

Article Genetics & Heredity

GATAD2B-associated neurodevelopmental disorder (GAND): clinical and molecular insights into a NuRD-related disorder

Christine Shieh, Natasha Jones, Brigitte Vanle, Margaret Au, Alden Y. Huang, Ana P. G. Silva, Hane Lee, Emilie D. Douine, Maria G. Otero, Andrew Choi, Katheryn Grand, Ingrid P. Taff, Mauricio R. Delgado, M. J. Hajianpour, Andrea Seeley, Luis Rohena, Hilary Vernon, Karen W. Gripp, Samantha A. Vergano, Sonal Mahida, Sakkubai Naidu, Ana Berta Sousa, Karen E. Wain, Thomas D. Challman, Geoffrey Beek, Donald Basel, Judith Ranells, Rosemarie Smith, Roman Yusupov, Mary-Louise Freckmann, Lisa Ohden, Laura Davis-Keppen, David Chitayat, James J. Dowling, Richard Finkel, Andrew Dauber, Rebecca Spillmann, Loren D. M. Pena, Kay Metcalfe, Miranda Splitt, Katherine Lachlan, Shane A. McKee, Jane Hurst, David R. Fitzpatrick, Jenny E. V. Morton, Helen Cox, Sunita Venkateswaran, Juan I. Young, Eric D. Marsh, Stanley F. Nelson, Julian A. Martinez, John M. Graham, Usha Kini, Joel P. Mackay, Tyler Mark Pierson

GENETICS IN MEDICINE (2020)

Article Clinical Neurology

Myopathy associated with homozygous PYROXD1 pathogenic variants detected by genome sequencing

Jeremy D. Woods, Negar Khanlou, Hane Lee, Rebecca Signer, Perry Shieh, Johnathan Chen, Matthew Herzog, Christina Palmer, Julian Martinez-Agosto, Stanley F. Nelson

NEUROPATHOLOGY (2020)

Article Biochemistry & Molecular Biology

Ppp1r1b-lncRNA inhibits PRC2 at myogenic regulatory genes to promote cardiac and skeletal muscle development in mouse and human

Xuedong Kang, Yan Zhao, Glen Van Arsdell, Stanley F. Nelson, Marlin Touma

Article Genetics & Heredity

Gene-environment regulation of chamber-specific maturation during hypoxemic perinatal circulatory transition

Yan Zhao, Xuedong Kang, Alexander Barsegian, Jian He, Alejandra Guzman, Ryan P. Lau, Reshma Biniwale, Madhuri Wadhra, Brian Reemtsen, Meena Garg, Nancy Halnon, Fabiola Quintero-Rivera, Wayne W. Grody, Glen Van Arsdell, Stanley F. Nelson, Marlin Touma

JOURNAL OF MOLECULAR MEDICINE-JMM (2020)

Article Medicine, General & Internal

Disseminated Coccidioidomycosis Treated with Interferon-gamma and Dupilumab

Monica Tsai, Timothy J. Thauland, Alden Y. Huang, Chantana Bun, Sean Fitzwater, Paul Krogstad, Emilie D. Douine, Stanley F. Nelson, Hane Lee, Maria I. Garcia-Lloret, Manish J. Butte

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Infectious Diseases

COVID-19 drug repurposing: Summary statistics on current clinical trials and promising untested candidates

J. Wes Ulm, Stanley F. Nelson

Summary: Repurposing existing drugs and therapies for COVID-19 shows promise in developing new control strategies. Untested small molecule antivirals previously showed specificity for SARS-CoV or MERS-CoV in vitro but have been largely overlooked in current COVID-19 trials.

TRANSBOUNDARY AND EMERGING DISEASES (2021)

Article Genetics & Heredity

Genetic characterization and long-term management of severely affected siblings with intellectual developmental disorder with cardiac arrhythmia syndrome

Shahram Yazdani, Anish Badjatiya, Naghmeh Dorrani, Hane Lee, Wayne W. Grody, Stanley F. Nelson, Katrina M. Dipple

MOLECULAR GENETICS AND METABOLISM REPORTS (2020)

Article Genetics & Heredity

Expansion of NEUROD2 phenotypes to include developmental delay without seizures

Emily K. Mis, Annalisa G. Sega, Rebecca H. Signer, Tracy Cartwright, Weizhen Ji, Julian A. Martinez-Agosto, Stanley F. Nelson, Christina G. S. Palmer, Hane Lee, Thomas Mitzelfelt, Monica Konstantino, Lauren Jeffries, Mustafa K. Khokha, Elysa Marco, Martin G. Martin, Saquib A. Lakhani

Summary: A novel de novo heterozygous NEUROD2 missense variant was found in an adolescent with developmental delay but without seizures, displaying minimal protein activity in functional testing. Another rare NEUROD2 variant identified in an adolescent with developmental delay showed normal NEUROD2 activity, suggesting that NEUROD2 variants can lead to developmental delay without early-onset seizures.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2021)

Article Biotechnology & Applied Microbiology

Role of cyanobacterial phosphoketolase in energy regulation and glucose secretion under dark anaerobic and osmotic stress conditions

Derrick Shih-Wei Chuang, James C. Liao

Summary: This study revealed the important role of phosphoketolase (Xpk) in primary metabolism of cyanobacteria, particularly in energy regulation and dark conditions. Additionally, Xpk is involved in the pathway producing ATP from glycogen to acetate. Deletion of xpk leads to glucose secretion under dark, anaerobic conditions.

METABOLIC ENGINEERING (2021)

Article Multidisciplinary Sciences

Quantitative immuno-mass spectrometry imaging of skeletal muscle dystrophin

David P. Bishop, Mika T. Westerhausen, Florian Barthelemy, Thomas Lockwood, Nerida Cole, Elizabeth M. Gibbs, Rachelle H. Crosbie, Stanley F. Nelson, M. Carrie Miceli, Philip A. Doble, Jonathan Wanagat

Summary: This study introduces a novel immuno-mass spectrometry imaging method for quantifying and localizing dystrophin in muscle tissue. The method was validated in mice, human skeletal muscle sections, and DMD patients with different gene mutations, demonstrating its potential for pre-clinical and clinical research in DMD.

SCIENTIFIC REPORTS (2021)

Article Genetics & Heredity

EIF3F-related neurodevelopmental disorder: refining the phenotypic and expanding the molecular spectrum

Ulrike Hueffmeier, Cornelia Kraus, Miriam S. Reuter, Steffen Uebe, Mary-Alice Abbott, Syed A. Ahmed, Kristyn L. Rawson, Eileen Barr, Hong Li, Ange-Line Bruel, Laurence Faivre, Frederic Tran Mau-Them, Christina Botti, Susan Brooks, Kaitlyn Burns, D. Isum Ward, Marina Dutra-Clarke, Julian A. Martinez-Agosto, Hane Lee, Stanley F. Nelson, Pia Zacher, Rami Abou Jamra, Chiara Kloeckner, Julie McGaughran, Juergen Kohlhase, Sarah Schuhmann, Ellen Moran, John Pappas, Annick Raas-Rothschild, Maria J. Guillen Sacoto, Lindsay B. Henderson, Timothy Blake Palculict, Sureni Mullegama, Houda Zghal Elloumi, Adi Reich, Samantha A. Schrier Vergano, Erica Wahl, Andre Reis, Christiane Zweier

Summary: The study identified an EIF3F variant associated with neurodevelopmental disorder, characterized by intellectual disability, epilepsy, and other symptoms. Patients showed developmental delays, behavioral problems, hearing loss, and short stature, with some also exhibiting microcephaly and reduced sensitivity to pain. A compound heterozygous individual had severe symptoms, suggesting genotype-phenotype correlation.

ORPHANET JOURNAL OF RARE DISEASES (2021)

Article Chemistry, Physical

A cell-free self-replenishing CO2-fixing system

Shanshan Luo, Paul P. Lin, Liang-Yu Nieh, Guan-Bo Liao, Po-Wen Tang, Chi Chen, James C. Liao

Summary: Biological CO2 fixation is the most effective method for large-scale CO2 reduction, accounting for the majority of CO2 fixed on Earth. Cell-free CO2 fixation systems offer an alternative approach, allowing independent control of the fixation rate. By designing an oxygen-insensitive, self-replenishing CO2 fixation system with opto-sensing, the researchers achieved a sustained CO2-fixing rate comparable to or greater than photosynthetic or lithoautotrophic organisms.

NATURE CATALYSIS (2022)

Article Cell Biology

Identification of COVID-19 B-cell epitopes with phage-displayed peptide library

Jing-You Guo, I-Ju Liu, Hsiu-Ting Lin, Mei-Jung Wang, Yu-Ling Chang, Shin-Chang Lin, Mei-Ying Liao, Wei-Chia Hsu, Yi-Ling Lin, James C. Liao, Han-Chung Wu

Summary: By using phage display technology and enzyme-linked immunosorbent assays, 36 enriched peptides were identified in the sera of two COVID-19 patients, with 4 motifs having consensus residues corresponding to two potential B-cell epitopes on SARS-CoV-2 viral proteins. These findings may aid in investigating COVID-19 pathogenesis and advancing the development of epitope-based serological diagnostics and vaccines.

JOURNAL OF BIOMEDICAL SCIENCE (2021)

No Data Available